MYCN amplification and ATRX mutations are incompatible in neuroblastoma

Authors

Maged Zeineldin, St. Jude's Children's Research Hospital, Memphis
Xiang Chen, Washington University School of Medicine in St. Louis
Michael A. Dyer, Washington University School of Medicine in St. Louis

Journal

Nature Communications

Publication Date

2020

Volume

11

Issue

1

First Page

913

Document Type

Open Access Publication

DOI

10.1038/s41467-020-14682-6

Rights and Permissions

Zeineldin, M., Federico, S., Chen, X., Fan, Y., Xu, B., Stewart, E., . . . Dyer, M. A. (2020). MYCN amplification and ATRX mutations are incompatible in neuroblastoma. Nature Communications, 11(1) doi:10.1038/s41467-020-14682-6 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

Recommended Citation

Zeineldin, Maged; Chen, Xiang; and Dyer, Michael A., "MYCN amplification and ATRX mutations are incompatible in neuroblastoma." Nature Communications. 11, 1. 913 (2020).
https://digitalcommons.wustl.edu/open_access_pubs/8940